ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Docebo Inc

Docebo Inc (DCBO)

44.72
0.72
(1.64%)
Closed April 28 4:00PM
45.10
0.38
(0.85%)
After Hours: 7:48PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
45.10
Bid
43.00
Ask
46.35
Volume
41,300
44.14 Day's Range 44.94
29.77 52 Week Range 56.41
Market Cap
Previous Close
44.00
Open
44.52
Last Trade Time
Financial Volume
$ 1,838,188
VWAP
44.5082
Average Volume (3m)
96,326
Shares Outstanding
31,717,338
Dividend Yield
-
PE Ratio
682.46
Earnings Per Share (EPS)
0.09
Revenue
180.84M
Net Profit
2.84M

About Docebo Inc

Docebo Inc offers cloud-based learning platform for both internal and external enterprise learning with real time tracking of training results, optimizing time, and reducing costs associated with traditional learning methods. Geographically, it holds presence in five offices around the world, includ... Docebo Inc offers cloud-based learning platform for both internal and external enterprise learning with real time tracking of training results, optimizing time, and reducing costs associated with traditional learning methods. Geographically, it holds presence in five offices around the world, including locations in Europe, Asia and North America. The firm derives its revenues from two main sources: software as-a-service application (SaaS); and professional services revenue, which includes services such as initial project management, training, and integration. Show more

Sector
Prepackaged Software
Industry
Prepackaged Software
Website
Headquarters
Toronto, Ontario, Can
Founded
1970
Docebo Inc is listed in the Prepackaged Software sector of the NASDAQ with ticker DCBO. The last closing price for Docebo was $44. Over the last year, Docebo shares have traded in a share price range of $ 29.77 to $ 56.41.

Docebo currently has 31,717,338 shares outstanding. The market capitalization of Docebo is $1.94 billion. Docebo has a price to earnings ratio (PE ratio) of 682.46.

DCBO Latest News

Docebo to Host First Quarter Fiscal 2024 Conference Call

Docebo Inc. (Nasdaq:DCBO; TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced that it will...

Docebo Announces Participation in Upcoming Investor Conferences in April

Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) (“Docebo” or the “Company”), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced today that...

U.S. Futures Pause Post-Nvidia Rally; WTI and Brent Decline in April Futures

In the pre-market on Friday, U.S. index futures showed a moderate trend, reflecting a pause after the euphoria outbreak in the market caused by Nvidia’s rally. This event led American...

Docebo to Host Fourth Quarter Fiscal 2023 Conference Call

Docebo Inc. (Nasdaq:DCBO; TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced today that it...

Docebo Recognized with 7 Brandon Hall Group Excellence in Technology Awards 2023

The 2023 Brandon Hall Group Excellence in Technology Awards recognizes Docebo for outstanding achievements in Future of Work, Learning and Development, and Sales Enablement Docebo Inc. (NASDAQ:...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.912.05928943244.1945.25543.455618744.41385189CS
4-3.88-7.9216006533348.9849.343.216033945.80967889CS
120.791.7828932520944.3156.4141.259632649.75143009CS
26718.372703412138.156.41379017948.26923515CS
52924.930747922436.156.4129.776542845.02304513CS
156-3.58-7.3541495480748.6892.7523.46766748.94948124CS
260-5.91-11.585963536651.0192.7523.46806548.85283427CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
SoxFan SoxFan 4 minutes ago
West Virginia is a model of education we should follow
Helter Skelter Helter Skelter 4 minutes ago
👉️ Dr Mike Chan cannot fail... 😺 It's just not possible.

Prof. Dato’ Sri Dr. Mike K.S. Chan is an author, educator and pioneer of Organotherapy, Cellular Therapy and Cell Membrane Therapy in Europe and Asia since the early 1980s. He founded and funded one o
NIVF
Kansasjack1 Kansasjack1 5 minutes ago
I too am super excited about the prospects of FBEC & the HAHALOLO Merger!!!

This is a multi Billion Dollar Merger!!!!!!
Wait for it! Wait for it!
Good things come to those who are patient!
FBEC
edcoolidge edcoolidge 5 minutes ago
I bet this WorstLuck person (who btw is the only person on this site I have muted) was buying ZM and DOCU in 2020 because "the market must be right." 😂
DOCU
WebSlinger WebSlinger 7 minutes ago
>

You are full of BS!

A few years ago, you admitted on this board that you sold shares. You have probably done that multiple times (all the while telling pe
KBLB
oak4life20 oak4life20 7 minutes ago
https://www.otcmarkets.com/otcapi/company/financial-report/399365/content
ASTA
Mutat Mutat 7 minutes ago
What will the new ticker name be?
IGPK
closetokathy closetokathy 8 minutes ago
I'm curious about all of those stocks that tat4tat was bashing. Have they lost value since his bashing.
CEOS
Genz2 Genz2 8 minutes ago
https://techxplore.com/news/2024-04-scientists-unveil-cybersecurity.amp

In the article it mentioned the ‘Secret AES encryption key’. The TPM has a public key and a private key and that together is stronger than just finding this ‘secret AES encryption key’ which I believe makes proces
AMD
Jetmek_03052 Jetmek_03052 8 minutes ago
I have dumbo's posts to prove his pumping ways. It is ALL HE DOES. He posts JUNK.

Let's see you prove that I short ANY stock....or where I have distorted anything in my posts.

I'll wait....
DBMM
Newtogame Newtogame 9 minutes ago
can i take a mulligan ?????
Brodey79 Brodey79 9 minutes ago
I’m hoping exchange approval comes out same time as filings. Then watch er move lol. But until anything comes out we’re not in the clear on everything going ahead as planned. We’ve already seen 2 failed acquisitions in GFL and Cim securities. This one should be different as the majority owner in Alc
FDCT
Brodey79 Brodey79 9 minutes ago
I’m hoping exchange approval comes out same time as filings. Then watch er move lol. But until anything comes out we’re not in the clear on everything going ahead as planned. We’ve already seen 2 failed acquisitions in GFL and Cim securities. This one should be different as the majority owner in Alc
FDCT
alertmeipp alertmeipp 9 minutes ago
IanFromSI, now we all know your motive here. lol.
So stupid
RVNC
edcoolidge edcoolidge 9 minutes ago
Jbog has become a complete clown.

Evolus licenses a toxin. They have no therapeutic program. They launched years before Daxxify. To compare expenses now is completely disingenuous. It's true Revance has overspent but they can and will cut expenses. If 3 years from now the situation ha
SitTight SitTight 10 minutes ago
New peer-reviewed Brilacidin publication: "Antifungal Activity of Brilacidin, a Nonpeptide Host Defense Molecule".
We studied brilacidin, an arylamide of this type, for its activity in vitro against fungi (40 clinical isolates, 20 species) that the World Health Organization has highlighted a
IPIX
Golden Cross Golden Cross 10 minutes ago
🧌Troll jimr1717 busy with his crayons today... No life loser🧌
IFUS
noradio noradio 12 minutes ago
Short and distort it up Jetmek!

Short and distort it GOOD!

LOL!
DBMM
LetGoodTimesRoll LetGoodTimesRoll 12 minutes ago
JT, buying is so slow, we've become the politics board....among other things.

Come one, come all!
RNVA
leverage102 leverage102 12 minutes ago
CORRECT, ALSO 23 MILLION DOLLARS IN REVENUE $$$$$$. * When the First Quarter of 2024 comes out could surpass the prior years Total revenue in the first 1/4 of 2024 $$$$$$
NSAV
KCCO7913 KCCO7913 12 minutes ago
You do realize that situation changes as soon as LWLG announces their Tier 1 partner? It’s likely LWLG’s foundry partner is either Tower Semi or SkyWater. I’d bet money at this point that the name of the foundry is going to remain secret for some time.

Interestingly enough in the las
LWLG

Your Recent History

Delayed Upgrade Clock